Katchanov, Juri <br/><br/>
Selective neuronal vulnerability following mild focal brain ischemia in the mouse.  [electronic resource] 

 -  Brain pathology (Zurich, Switzerland)  Oct 2003 
 - 452-64 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1015-6305 
<br/><br/><label>Standard No.: </label>10.1111/j.1750-3639.2003.tb00476.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Amino-5-phosphonovalerate--analogs & derivatives<br/>Animals<br/>Antidotes--pharmacokinetics<br/>Antineoplastic Agents--pharmacokinetics<br/>Autoradiography--methods<br/>Binding Sites<br/>Brain Ischemia--etiology<br/>Calbindin 2<br/>Cell Count--methods<br/>Cell Survival<br/>Choline O-Acetyltransferase--metabolism<br/>Corpus Striatum--drug effects<br/>Disease Models, Animal<br/>Excitatory Amino Acid Antagonists--pharmacokinetics<br/>Flumazenil--pharmacokinetics<br/>Functional Laterality<br/>Immunohistochemistry--methods<br/>In Situ Nick-End Labeling--methods<br/>Infarction, Middle Cerebral Artery--complications<br/>Isoquinolines--pharmacokinetics<br/>Mice<br/>Neurons--drug effects<br/>Parvalbumins<br/>Phosphopyruvate Hydratase--metabolism<br/>S100 Calcium Binding Protein G--metabolism<br/>Somatostatin--metabolism<br/>Staining and Labeling<br/>Time Factors<br/>Tritium--pharmacokinetics